{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:25:41Z","timestamp":1764732341770},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T00:00:00Z","timestamp":1159401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T00:00:00Z","timestamp":1159401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s00417-006-0436-x","type":"journal-article","created":{"date-parts":[[2006,9,27]],"date-time":"2006-09-27T10:16:04Z","timestamp":1159352164000},"page":"689-696","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Influence of different purification techniques on triamcinolone yield and particle size spectrum"],"prefix":"10.1007","volume":"245","author":[{"given":"Peter","family":"Szurman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radoslaw","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gesine B.","family":"Jaissle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"L\u00fcke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter-Edgar","family":"Heide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl U.","family":"Bartz-Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,28]]},"reference":[{"key":"436_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","volume":"108","author":"RJ Antcliff","year":"2001","unstructured":"Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108:765\u2013772","journal-title":"Ophthalmology"},{"key":"436_CR2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-9394(14)76037-4","volume":"99","author":"DB Chandler","year":"1985","unstructured":"Chandler DB, Rozakis G, de Juan E, Machemer R (1985) The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy. Am J Ophthalmol 99:686\u2013690","journal-title":"Am J Ophthalmol"},{"key":"436_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00006982-200005000-00003","volume":"20","author":"RP Danis","year":"2000","unstructured":"Danis RP, Ciulla TA, Pratt LM, Anliker W (2000) Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20:244\u2013250","journal-title":"Retina"},{"key":"436_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/bjo.2005.067744","volume":"89","author":"J Garcia-Arumi","year":"2005","unstructured":"Garcia-Arumi J, Boixadera A, Giralt J, Martinez-Castillo V, Gomez-Ulla F, Corcostegui B, Garcia-Arumi E (2005) Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use. Br J Ophthalmol 89:1112\u20131114","journal-title":"Br J Ophthalmol"},{"key":"436_CR5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3928\/1542-8877-20040701-18","volume":"35","author":"MC Hernaez-Ortega","year":"2004","unstructured":"Hernaez-Ortega MC, Soto-Pedre E (2004) A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection. Ophthalmic Surg Lasers Imaging 35:350\u2013351","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"436_CR6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3928\/1542-8877-20060301-16","volume":"37","author":"MC Hernaez-Ortega","year":"2006","unstructured":"Hernaez-Ortega MC, Soto-Pedre E (2006) Removal of benzyl alcohol from a commercially available triamcinolone acetonide suspension for intravitreal use. Ophthalmic Surg Lasers Imaging 37:162\u2013164","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"436_CR7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","volume":"101","author":"T Hida","year":"1986","unstructured":"Hida T, Chandler D, Arena JE, Machemer R (1986) Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 101:190\u2013195","journal-title":"Am J Ophthalmol"},{"key":"436_CR8","first-page":"231","volume":"26","author":"T Hoppe-Tichy","year":"2005","unstructured":"Hoppe-Tichy T, B\u00e4r W, Schmitt S (2005) Zwei intravitreal applizierbare Triamcinolonacetonid-Suspensionen im Vergleich. Krankenhauspharmazie 26:231\u2013232","journal-title":"Krankenhauspharmazie"},{"key":"436_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00347-003-0975-z","volume":"101","author":"GB Jaissle","year":"2004","unstructured":"Jaissle GB, Szurman P, Bartz-Schmidt KU (2004) Ocular side effects and complications of intravitreal triamcinolone acetonide Injection. Ophthalmologe 101:121\u2013128","journal-title":"Ophthalmologe"},{"key":"436_CR10","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","volume":"84","author":"JB Jonas","year":"2000","unstructured":"Jonas JB, Hayler JK, Panda-Jonas S (2000) Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 84:1064\u20131067","journal-title":"Br J Ophthalmol"},{"key":"436_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1001\/archopht.122.2.218","volume":"122","author":"JB Jonas","year":"2004","unstructured":"Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF (2004) Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol 122:218\u2013222","journal-title":"Arch Ophthalmol"},{"key":"436_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ajo.2003.08.012","volume":"137","author":"JB Jonas","year":"2004","unstructured":"Jonas JB (2004) Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol 137:560\u2013562","journal-title":"Am J Ophthalmol"},{"key":"436_CR13","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","volume":"109","author":"A Martidis","year":"2002","unstructured":"Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920\u2013927","journal-title":"Ophthalmology"},{"key":"436_CR14","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/00006982-200412000-00009","volume":"24","author":"JO Mason","year":"2004","unstructured":"Mason JO, Somaiya MD, Singh RJ (2004) Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes. Retina 24:900\u2013904","journal-title":"Retina"},{"key":"436_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00006982-200603000-00014","volume":"26","author":"VL Morrison","year":"2006","unstructured":"Morrison VL, Koh HJ, Chen L, Bessho K, Davidson MC (2006) Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina 26:339\u2013344","journal-title":"Retina"},{"key":"436_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/00006982-200312000-00005","volume":"23","author":"A Nishimura","year":"2003","unstructured":"Nishimura A, Kobayashi A, Segawa Y, Sakurai M, Shirao E, Shirao Y, Sugiyama K (2003) Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter. Retina 23:777\u2013779","journal-title":"Retina"},{"key":"436_CR17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/archopht.122.7.1085","volume":"122","author":"H Rodriguez-Coleman","year":"2004","unstructured":"Rodriguez-Coleman H, Yuan P, Kim H, Gravlin L, Srivastava S, Csaky KG, Robinson MR (2004) Intravitreal injection of triamcinolone for diffuse macular edema. Arch Ophthalmol 122:1085\u20131086","journal-title":"Arch Ophthalmol"},{"key":"436_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/archopht.123.1.129-b","volume":"123","author":"JM Ruiz-Moreno","year":"2005","unstructured":"Ruiz-Moreno JM, Montero JA, Artola A, Barile S (2005) Anterior chamber transit of triamcinolone after intravitreal injection. Arch Ophthalmol 123:129\u2013130","journal-title":"Arch Ophthalmol"},{"key":"436_CR19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(82)90130-1","volume":"93","author":"RH Schindler","year":"1982","unstructured":"Schindler RH, Chandler D, Thresher R, Machemer R (1982) The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 93:415\u2013417","journal-title":"Am J Ophthalmol"},{"key":"436_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.exer.2006.02.012","volume":"83","author":"P Szurman","year":"2006","unstructured":"Szurman P, Kaczmarek R, Spitzer MS, Jaissle GB, Decker P, Grisanti S, Henke-Fahle S, Aisenbrey S, Bartz-Schmidt KU (2006) Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells. Exp Eye Res 83:584\u2013592, Epub","journal-title":"Exp Eye Res"},{"key":"436_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/026119299302100222","volume":"21","author":"P Winkelmeier","year":"1993","unstructured":"Winkelmeier P, Glauner B, Lindl T (1993) Quantitation of cytotoxicity by cell volume and cell proliferation. Altern Lab Anim 21:269\u2013280","journal-title":"Altern Lab Anim"},{"key":"436_CR22","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1167\/iovs.03-0490","volume":"44","author":"CK Yeung","year":"2003","unstructured":"Yeung CK, Chan KP, Chiang SWY, Pang CP, Lam DSC (2003) The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 44:5293\u20135300","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-006-0436-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0436-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T19:20:51Z","timestamp":1652815251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-006-0436-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,28]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["436"],"URL":"https:\/\/doi.org\/10.1007\/s00417-006-0436-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,28]]},"assertion":[{"value":"1 June 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}